Dr. Magliocco to Present at Future Genomics 2023

Dr. Magliocco will be presenting a special lecture at Future Genomics 2023 on the roles of genomic testing technology for improving the diagnosis and treatment of cancer patients.

 Topics will include:

• Implementing WES as part of the Protean MAPS™ precision oncology system

• Clinical uses of multiplex IHC for analysis of PDL1 in cancer specimens

• How the Protean MAPS™ system delivers fully integrated multiomics data for cancer patients

Dr. Magliocco is the Founder and CEO of Protean BioDiagnostics, the home of Protean MAPS™ the most innovative precision cancer diagnostic platform available, focused on improving outcomes in cancer patients using integrated diagnostics, pathology, genomics, molecular diagnostics, AI and telemedicine.

---

Meeting Details

Dates:
Match 22-23, 2023

Location:
Kimpton Marlow Hotel
Cambridge, Massachusetts

Pre-register for Presentation

PRE-REGISTRATION

---

For further information, please contact:

Anthony Magliocco MD
CEO & President of Protean BioDiagnostics

Email: info@proteanbiodx.com
Phone: 1 (813) 817 2042

---